HSPC196 operate through a variety of intracellular signaling pathways, engaging different molecular mechanisms to elicit the activation of this protein. Forskolin, a diterpene, directly stimulates adenylyl cyclase, which catalyzes the conversion of ATP to cAMP, a secondary messenger that activates protein kinase A (PKA). Upon activation, PKA phosphorylates HSPC196, modulating its activity. Similarly, Isoproterenol, a synthetic catecholamine, engages beta-adrenergic receptors to activate adenylyl cyclase, leading to an increase in cAMP levels and subsequent PKA-mediated phosphorylation of HSPC196. Another compound, 8-Bromo-cAMP, a cAMP analog, bypasses the upstream receptors and adenylyl cyclase activation step, directly initiating PKA activation and the subsequent phosphorylation of HSPC196. Parathyroid hormone fragment PTH (1-34) also triggers this cascade by binding to its receptor, thereby increasing cAMP levels and activating PKA, which then acts on HSPC196.
Anisomycin, which activates stress-activated protein kinases such as p38 MAPK and JNK that are known to phosphorylate HSPC196. Ionomycin, a calcium ionophore, elevates intracellular calcium levels, which can stimulate calcium-dependent protein kinases that may target and phosphorylate HSPC196. Thapsigargin, which disrupts calcium homeostasis by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase, raises cytosolic calcium levels, also leading to the activation of calcium-dependent kinases that can phosphorylate HSPC196. Phorbol 12-myristate 13-acetate (PMA) activates protein kinase C (PKC), which then phosphorylates HSPC196. Growth factors such as Epidermal Growth Factor (EGF) and hormones like Insulin can also promote the phosphorylation of HSPC196 through the activation of specific kinase pathways, including MAPK/ERK for EGF and PI3K/Akt pathway for Insulin. Lastly, BAY 60-6583 selectively activates the adenosine A2B receptor, which increases intracellular cAMP levels, leading to PKA activation and subsequent phosphorylation of HSPC196. Each of these chemicals engages distinct pathways to converge on the activation of HSPC196, highlighting the protein's integration into multiple cellular processes.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Isoproterenol Hydrochloride | 51-30-9 | sc-202188 sc-202188A | 100 mg 500 mg | $28.00 $38.00 | 5 | |
Isoproterenol is a beta-adrenergic agonist that promotes the activation of adenylyl cyclase, thus increasing cAMP levels and subsequently activating PKA. PKA then phosphorylates HSPC196, resulting in its activation. | ||||||
8-Bromo-cAMP | 76939-46-3 | sc-201564 sc-201564A | 10 mg 50 mg | $126.00 $328.00 | 30 | |
As a cAMP analog, 8-Bromo-cAMP directly activates PKA without the need for adenylyl cyclase. Activated PKA phosphorylates HSPC196, leading to its activation. | ||||||
Parathyroid hormone fragment (1-34) | 52232-67-4 | sc-487943 | 100 µg | $185.00 | ||
Parathyroid hormone fragment PTH (1-34) engages the PTH receptor, leading to adenylyl cyclase activation, cAMP production, PKA activation, and subsequent phosphorylation and activation of HSPC196. | ||||||
Anisomycin | 22862-76-6 | sc-3524 sc-3524A | 5 mg 50 mg | $99.00 $259.00 | 36 | |
Anisomycin is a potent activator of stress-activated protein kinases, such as p38 MAPK and JNK. These kinases can phosphorylate HSPC196, leading to its functional activation in a stress response context. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that raises intracellular calcium levels, potentially activating calcium-dependent protein kinases which might phosphorylate and activate HSPC196. | ||||||
Retinoic Acid, all trans | 302-79-4 | sc-200898 sc-200898A sc-200898B sc-200898C | 500 mg 5 g 10 g 100 g | $66.00 $325.00 $587.00 $1018.00 | 28 | |
Retinoic acid can activate specific kinase pathways involved in cell differentiation that may phosphorylate HSPC196, thereby increasing its functional activity. | ||||||
Thapsigargin | 67526-95-8 | sc-24017 sc-24017A | 1 mg 5 mg | $136.00 $446.00 | 114 | |
Thapsigargin disrupts calcium homeostasis by inhibiting the sarco/endoplasmic reticulum Ca2+-ATPase (SERCA), leading to an increase in cytosolic calcium which activates calcium-dependent kinases that could phosphorylate and activate HSPC196. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA is a diacylglycerol analog that activates protein kinase C (PKC), which can phosphorylate HSPC196, resulting in its activation. | ||||||
Insulin | 11061-68-0 | sc-29062 sc-29062A sc-29062B | 100 mg 1 g 10 g | $156.00 $1248.00 $12508.00 | 82 | |
Insulin activates the PI3K/Akt signaling pathway, leading to phosphorylation and activation of various downstream proteins, potentially including HSPC196. | ||||||
BAY 60-6583 | 910487-58-0 | sc-503262 | 10 mg | $210.00 | ||
BAY 60-6583 selectively activates the adenosine A2B receptor, leading to increased intracellular cAMP, PKA activation, and the subsequent phosphorylation and activation of HSPC196. | ||||||